Pfeffer M.A. Shah A.M. Borlaug B.A.

Heart failure with preserved ejection fraction in Perspective.

Circ Res. 124: 1598-1617

Evaluation and management of heart failure with preserved ejection fraction.

Nat Rev Cardiol. 17: 559-573https://doi.org/10.1038/s41569-020-0363-2Pieske B. Tschöpe C. de Boer R.A. et al.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Eur Heart J. 40: 3297-3317Omote K. Verbrugge F.H. Borlaug B.A.

Heart failure with preserved ejection fraction: Mechanisms and treatment Strategies.

Annu Rev Med. 73: 321-337Abudiab M.M. Redfield M.M. Melenovsky V. et al.

Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Eur J Heart Fail. 15: 776-785Borlaug B.A. Kane G.C. Melenovsky V. et al.

Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.

Eur Heart J. 37: 3293-3302Dhakal B.P. Malhotra R. Murphy R.M. et al.

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

Circ Heart Fail. 8: 286-294

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction.

Circ J. 78: 20-32Gorter T.M. Obokata M. Reddy Y.N.V. et al.

Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Eur Heart J. 39: 2825-2835Verbrugge F.H. Omote K. Reddy Y.N.V. et al.

Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.

Eur Heart J. 43: 1941-1951Obokata M. Kane G.C. Reddy Y.N. et al.

Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study.

Circulation. 135: 825-838Borlaug B.A. Nishimura R.A. Sorajja P. et al.

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Circ Heart Fail. 3: 588-595Reddy Y.N.V. Carter R.E. Obokata M. et al.

A Simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction.

Circulation. 138: 861-870Borlaug B.A. Redfield M.M.

Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.

Circulation. 123 (): 2006-2013Sorimachi H. Verbrugge F.H. Omote K. et al.

Longitudinal Evolution of cardiac dysfunction in heart failure with normal natriuretic peptide levels.

Circulation. 146: 500-502Nauta J.F. Hummel Y.M. van der Meer P. et al.

Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fraction.

Eur J Heart Fail. 20: 1303-1311Hsu S. Fang J.C. Borlaug B.A.

Hemodynamics for the heart failure clinician: a state-of-the-Art review.

J Card Fail. 28: 133-148Guazzi M. Adams V. Conraads V. et al.

EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Circulation. 126: 2261-2274Guazzi M. Arena R. Halle M. et al.

Focused Update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Circulation. 133: e694-e711Malhotra R. Bakken K. D'Elia E. et al.

Cardiopulmonary exercise testing in heart failure.

JACC Heart Fail. 4: 607-616Redfield M.M. Chen H.H. Borlaug B.A. et al.

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Jama. 309: 1268-1277Borlaug B.A. Anstrom K.J. Lewis G.D. et al.

Effect of Inorganic Nitrite vs Placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial.

Jama. 320: 1764-1773Guazzi M. Myers J. Arena R.

Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure.

J Am Coll Cardiol. 46: 1883-1890Guazzi M. Labate V. Cahalin L.P. et al.

Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.

Eur J Prev Cardiol. 21: 847-854Haykowsky M.J. Brubaker P.H. John J.M. et al.

Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.

J Am Coll Cardiol. 58: 265-274Chomsky D.B. Lang C.C. Rayos G.H. et al.

Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates.

Circulation. 94: 3176-3183Sullivan M.J. Knight J.D. Higginbotham M.B. et al.

Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure.

Circulation. 80: 769-781Reddy Y.N.V. Obokata M. Wiley B. et al.

Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure with Preserved Ejection Fraction.

JACC Heart Fail. 6: 665-675Van Iterson E.H. Johnson B.D. Borlaug B.A. et al.

Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.

Eur J Heart Fail. 19: 1675-1685Obokata M. Olson T.P. Reddy Y.N.V. et al.

Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction.

Eur Heart J. 39: 2810-2821

The pulmonary manifestations of left heart failure.

Chest. 125: 669-682Stavrakis S. Elkholey K. Morris L. et al.

Neuromodulation of Inflammation to Treat heart failure with preserved ejection fraction: a Pilot randomized clinical trial.

J Am Heart Assoc. 11e023582

Performance and interpretation of invasive hemodynamic exercise testing.

Chest. 158: 2119-2129Obokata M. Reddy Y.N.V. Pislaru S.V. et al.

Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction.

Circulation. 136: 6-19Reddy Y.N.V. Obokata M. Verbrugge F.H. et al.

Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation.

J Am Coll Cardiol. 76: 1051-1064Mizumi S. Goda A. Takeuchi K. et al.

Effects of body position during cardiopulmonary exercise testing with right heart catheterization.

Physiol Rep. 6e13945

Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects.

Am J Cardiol. 41: 52-59West J.B. Dollery C.T. Naimark A.

Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures.

J Appl Phys. 19: 713-724Stampfer M. Epstein S.E. Beiser G.D. et al.

Exercise in patients with heart disease. Effects of body position and type and intensity of exercise.

Am J Cardiol. 23: 572-576van de Bovenkamp A.A. Wijkstra N. Oosterveer F.P.T. et al.

The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction.

Circulation Heart failure. 15: e008935Sorimachi H. Burkhoff D. Verbrugge F.H. et al.

Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction.

Eur J Heart Fail. 23: 1648-1658Sorimachi H. Obokata M. Takahashi N. et al.

Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction.

Eur Heart J. 42: 1595-1605

Left atrial myopathy in heart failure with preserved ejection fraction.

Circ J. ()https://doi.org/10.1253/circj.CJ-21-0795Vachiery J.L. Tedford R.J. Rosenkranz S. et al.

Pulmonary hypertension due to left heart disease.

Eur Respir J. 53Epstein S.E. Beiser G.D. Stampfer M. et al.

Characterization of the circulatory response to maximal upright exercise in normal subjects and patients with heart disease.

Circulation. 35: 1049-1062

Ho JE, Zern EK, Lau ES, et al. Exercise pulmonary hypertension Predicts clinical Outcomes in patients with dyspnea on effort. J Am Coll Cardiol 2020;75:17–26.

Eisman A.S. Shah R.V. Dhakal B.P. et al.

Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure.

Circ Heart Fail. 11e004750Andersen M.J. Nishimura R.A. Borlaug B.A.

The hemodynamic basis of exercise intolerance in tricuspid regurgitation.

Circ Heart Fail. 7: 911-917Belenkie I. Dani R. Smith E.R. et al.

Effects of volume loading during experimental acute pulmonary embolism.

Circulation. 80: 178-188Tyberg J.V. Taichman G.C. Smith E.R. et al.

The relationship between pericardial pressure and right atrial pressure: an intraoperative study.

Circulation. 73: 428-432Borlaug B.A. Reddy Y.N.V.

The role of the pericardium in heart failure: implications for pathophysiology and treatment.

JACC Heart Fail. 7: 574-585Nagata R. Harada T. Omote K. et al.

Right atrial pressure represents cumulative cardiac burden in heart failure with preserved ejection fraction.

ESC Heart Fail. 9: 1454-1462https://doi.org/10.1002/ehf2.13853Omote K. Sorimachi H. Obokata M. et al.

Pulmonary Vascular Disease in Pulmonary Hypertension Due to Left Heart Disease: Pathophysiologic Implications.

Eur Heart J. 7 (): ehac184https://doi.org/10.1093/eurheartj/ehac184Omote K. Nagai T. Kamiya K. et al.

Long-term prognostic significance of Admission tricuspid regurgitation pressure Gradient in Hospitalized patients with heart failure with preserved ejection fraction: a report from the Japanese Real-World Multicenter Registry.

J Card Fail. 25: 978-985Freed B.H. Daruwalla V. Cheng J.Y. et al.

Prognostic utility and clinical significance of cardiac Mechanics in heart failure with preserved ejection fraction: importance of left atrial strain.

Circ Cardiovasc Imaging. 9Melenovsky V. Hwang S.J. Redfield M.M. et al.

Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.

Circ Heart Fail. 8: 295-303Guazzi M. Dixon D. Labate V. et al.

RV contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction: Stratification of clinical phenotypes and Outcomes.

JACC Cardiovasc Imaging. 10: 1211-1221Melenovsky V. Hwang S.J. Lin G. et al.

Right heart dysfunction in heart failure with preserved ejection fraction.

Eur Heart J. 35: 3452-3462Obokata M. Reddy Y.N.V. Melenovsky V. et al.

Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.

Eur Heart J. 40: 689-697Sugimoto T. Bandera F. Generati G. et al.

Left atrial function Dynamics during exercise in heart failure: pathophysiological implications on the right heart and exercise ventilation inefficiency.

JACC Cardiovasc Imaging. 10: 1253-1264Kelly R.P. Ting C.T. Yang T.M. et al.

Effective arterial elastance as index of arterial vascular load in humans.

Circulation. 86: 513-521Chemla D. Hébert J.L. Coirault C. et al.

Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans.

Am J Phys. 274: H500-H505

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Eur Heart J. 32: 670-679Reddy Y.N.V. Andersen M.J. Obokata M. et al.

Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction.

J Am Coll Cardiol. 70: 136-148Lau E.S. Panah L.G. Zern E.K. et al.

Arterial stiffness and vascular load in HFpEF: differences among women and men.

J Card Fail. 28: 202-211Houstis N.E. Eisman A.S. Pappagianopoulos P.P. et al.

Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and Ranking its causes using Personalized O(2) Pathway analysis.

Circulation. 137: 148-161Melamed K.H. Santos M. Oliveira R.K.F. et al.

Unexplained exertional intolerance associated with impaired systemic oxygen extraction.

Eur J Appl Physiol. 119: 2375-2389Reddy Y.N.V. Obokata M. Egbe A. et al.

Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction.

Eur J Heart Fail. 21: 891-900Koepp K.E. Obokata M. Reddy Y.N.V. et al.

Hemodynamic and functional impact of Epicardial adipose tissue in heart failure with preserved ejection fraction.

JACC Heart Fail. 8: 657-666Sorimachi H. Omote K. Borlaug B.A.

Clinical phenogroups in heart failure with preserved ejection fraction.

Heart Fail Clin. 17: 483-498Shah S.J. Borlaug B.A. Chung E.S. et al.

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Lancet. 399: 1130-1140https://doi.org/10.1016/S0140-6736(22)00016-2Borlaug B.A. Blair J. Bergmann M.W. et al.

Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.

Circulation. 145: 1592-1604https://doi.org/10.1161/CIRCULATIONAHA.122.059486